Clavamox combination dry syrup for pediatric use, manufactured by GlaxoSmithKline, contains Amoxicillin hydrate/potassium clavulanate. This antibiotic combination, identified by YJ code 6139100R1036 and a standard of (636.5mg) per 1g, is used for pediatric bacterial infections.
Clavamox combination dry syrup for pediatric use
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
